Cited by 390T-cell and B-cell ImmunologyCancer Immunotherapy and BiomarkersReproductive System and Pregnancy

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Cutting Edge: Molecular Analysis of the Negative Regulatory Function of Lymphocyte Activation Gene-3

Workman, Creg J, Dugger, Kari J, Vignali, Dario A A·2002·The Journal of Immunology

Open this paper in CoChat — free account

Abstract

Lymphocyte activation gene (LAG)-3 (CD223) is a CD4-related activation-induced cell surface molecule that binds to MHC class II molecules with high affinity and negatively regulates T cell expansion and homeostasis. In this study, we show that LAG-3 inhibits CD4-dependent, but not CD4-independent, T cell function via its cytoplasmic domain. Although high affinity interaction with MHC class II molecules is essential for LAG-3 function, tailless LAG-3 does not compete with CD4 for ligand binding. A single lysine residue (K468) within a conserved "KIEELE" motif is essential for interaction with downstream signaling molecules. These data provide insight into the mechanism of action of this important T cell regulatory molecule.

Integrity signals

Registry

Crossref · 10.4049/jimmunol.169.10.5392

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717
LAG-3, a novel lymphocyte activation gene closely related to CD4.
Triebel, F., Jitsukawa, S., Baixerás, E., Roman‐Roman, S., Genevée, C., Viégas-Pèquignot, E., & Hercend, T. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.5.1393 · Cited by 936
Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens.
Baixerás, E., Huard, B., Miossec, C., Jitsukawa, S., Martin, M., Hercend, T., Auffray, C., Triebel, F., & Piatier‐Tonneau, D. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.2.327 · Cited by 397
CD4/major histocompatibility complex class II interaction analyzed with CD4‐ and lymphocyte activation gene‐3 (LAG‐3)‐Ig fusion proteins
Huard, B., Prigent, P., Tournier, M., Bruniquel, D., & Triebel, F. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250949 · Cited by 391
Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: evidence for more than one receptor class.
Gronwald, R. G., Grant, F. J., Haldeman, B. A., Hart, C. E., O’Hara, P. J., Hagen, F. S., Ross, R., Bowen‐Pope, D. F., & Murray, M. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.10.3435 · Cited by 316
Characterization of the major histocompatibility complex class II binding site on LAG-3 protein
Huard, B., Mastrangeli, R., Prigent, P., Bruniquel, D., Donini, S., Tayar, N. E., Maigret, B., Dréano, M., & Triebel, F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.11.5744 · Cited by 308
CD3/TCR complex‐associated lymphocyte activation gene‐3 molecules inhibit CD3/TCR signaling
Hannier, S., Tournier, M., Bismuth, G., & Triebel, F. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.8.4058 · Cited by 248
Peroxisome proliferator-activated receptor γ activators affect the maturation of human monocyte-derived dendritic cells
Gosset, P., Charbonnier, A.-S., Delerive, P., Fontaine, J., Staels, B., Pestel, J., Tonnel, A., & Trottein, F. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(2001010)31:10 · Cited by 225
Retroviral-Mediated Transfer of the Green Fluorescent Protein Gene Into Murine Hematopoietic Cells Facilitates Scoring and Selection of Transduced Progenitors In Vitro and Identification of Genetically Modified Cells In Vivo
Persons, D. A., Allay, J. A., Allay, E. R., Smeyne, R. J., Ashmun, R. A., Sorrentino, B. P., & Nienhuis, A. W. (1997) · Blood · doi:10.1182/blood.v90.5.1777 · Cited by 222
Cellular expression and tissue distribution of the human LAG-3-encoded protein, an MHC class II ligand
Huard, B., Gaulard, P., Faure, F., Hercend, T., & Triebel, F. (1994) · Immunogenetics · doi:10.1007/bf00241263 · Cited by 202

Show all 26 references

Research works printed but not linked: 25

1996, Annu. Rev. Immunol, 233
1996, Eur. J. Immunol., 1180
1992, J. Exp. Med., 327
1998, J. Immunol., 4058
1990, J. Exp. Med., 1393
1997, Immunogenetics, 96
1997, Proc. Natl. Acad. Sci. USA, 5744
1994, Immunogenetics, 213
2002, Eur. J. Immunol., 2255
1995, Eur. J. Immunol., 2718
1996, Science, 405
1996, Anal. Biochem., 93
1995, EMBO J., 3403
1994, J. Immunol., 642
1988, Proc. Natl. Acad. Sci. USA, 3435
1999, J. Immunol., 1431
1997, Blood, 1777
1998, Blood Cells Mol. Dis., 167
1985, J. Exp. Med., 1264
1994, J. Exp. Med., 1945
J. Immunol., 739
1997, Immunity, 387
1993, Int. Immunol., 695
2001, Eur. J. Immunol., 2885
1999, Int. Immunol., 1745

Sorted by citations

Items 301–390 of 390

Protein Receptors Evolved from Homologous Cohesion Modules That Self-Associated and Are Encoded by Interactive Networked Genes
Dwyer, D. S. (2021) · Life · doi:10.3390/life11121335 · Cited by 4
Unlocking therapeutic potential: Targeting lymphocyte activation Gene-3 (LAG-3) with fibrinogen-like protein 1 (FGL1) in systemic lupus erythematosus
Wang, B., Zhang, B., Wu, M., & Xu, T. (2024) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2024.100249 · Cited by 3
Emerging roles of checkpoint molecules on B cells
Asashima, H., Akao, S., & Matsumoto, I. (2025) · Immunological Medicine · doi:10.1080/25785826.2025.2454045 · Cited by 3
New horizons in B-cell lymphoma immunotherapy: From immune checkpoints to precision medicine
Zheng, R., Li, Y., Shi, K., Pan, Y., Liu, K., Song, J., & Li, L. (2025) · Neoplasia · doi:10.1016/j.neo.2025.101206 · Cited by 4
Cell Activation and Signaling in Lymphocytes
Carmo, A. M., & Henriques, S. N. (2020) · Springer eBooks · doi:10.1007/978-3-030-44436-5_5 · Cited by 3
Lymphocyte activation gene 3 served as a potential prognostic and immunological biomarker across various cancer types: a clinical and pan‐cancer analysis
Liu, Y., Yao, Y., Yang, X., Wei, M., Lu, B., Dong, K., Lyu, D., Li, Y., Guan, W., Huang, R., et al. (2024) · Clinical & Translational Immunology · doi:10.1002/cti2.70009 · Cited by 4
Advances of Immune Checkpoint Inhibitors in Tumor Immunotherapy
Guo, Q. (2018) · IOP Conference Series Materials Science and Engineering · doi:10.1088/1757-899x/301/1/012020 · Cited by 3
Das Tumormikromilieu bei Speicheldrüsenkarzinomen – mögliche Konsequenzen für neue Therapiekonzepte
Meyer, M. F., Arolt, C., Kansy, B., Doescher, J., Quaas, A., Beutner, D., Lang, S., & Klußmann, J. P. (2020) · HNO · doi:10.1007/s00106-020-00926-w · Cited by 3
Cancer Vaccines
Bot, A. I., Berinstein, E. M., & Berinstein, N. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00013-4 · Cited by 3
Distinct immune-response profile of Richter transformation chronic lymphocytic leukemia (CLL), defined by high expression of PD1, LAG3, TIM3 and IL-10
Behdad, A., Schipma, M. J., Ma, S., Chen, Y., & Chen, Q. C. (2022) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2022.2123236 · Cited by 3
Immunotherapy for Cutaneous Melanoma
Soleymanitabar, A., Keshavarz‐Fathi, M., Hargadon, K. M., & Rezaei, N. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_237-1 · Cited by 2
Using the Rise and Fall of Oxidative Stress and Inflammation Post-Exercise to Evaluate the Effect of Methylsulfonylmethane Supplementation on Immune Response mRNA
McFarlin, B. K., Curtis, J. H., du Preez, H. N., & McFarlin, M. A. (2025) · Nutrients · doi:10.3390/nu17111761 · Cited by 2
Beyond monotherapy: multimodal strategies integrating immune checkpoint inhibitors in lymphoma management
Li, Y., Zheng, R., Pan, B., Wang, X., Zhang, L., Gao, H., & Li, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1713199 · Cited by 3
LAG-3 in (auto)immunity and cancer - Emphasising its role in antigen presenting cells
Wiśniewska, A., Sarnowska, E. A., Kozak, K., Rutkowski, P., & Sobczuk, P. (2026) · Autoimmunity Reviews · doi:10.1016/j.autrev.2026.103992 · Cited by 2
Sex Hormones-Mediated Modulation of Immune Checkpoints in Pregnancy and Recurrent Pregnancy Loss
Zych, M., Roszczyk, A., Zakrzewska, M., Zagożdżon, R., Pączek, L., Dąbrowski, F. A., & Kniotek, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031265 · Cited by 2
Unraveling fibrinogen-like protein 1’s role in immune regulation
Xi, F., & Liu, R. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1753785 · Cited by 2
Targeting of Inhibitory Immune Receptors in Inflammatory Disease Guided by Molecular Understanding of Their Function
Meyaard, L., & van der Vlist, M. (2026) · Annual Review of Immunology · doi:10.1146/annurev-immunol-083024-025659 · Cited by 3
Unraveling Immune Checkpoint Inhibitor-Associated Cardiovascular Toxicities: Pathway Insights, Mechanisms, and Emerging Therapeutic Targets
Zhang, B., Muhetarijiang, M., Sun, X., Wu, Y., Justin, R., Li, Z., Chen, T., Zhou, D., & Hu, X. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm43846 · Cited by 2
Exploring the molecular landscape of lymphocyte activation gene-3: A literature review
Nie, J., Qin, X. Y., Tao, X., & Jin, H. (2024) · Medicine · doi:10.1097/md.0000000000039622 · Cited by 2
Immune checkpoints in B-cell Lymphoma: Still an Unmet challenge from Basic research to clinical practice
Li, S., Pan, Y., Ye, R., Wang, Y., & Li, L. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113717 · Cited by 2
Immune checkpoints and ncRNAs: pioneering immunotherapy approaches for hematological malignancies
Anvari, S., Nikbakht, M., Vaezi, M., Amini‐Kafiabad, S., & Ahmadvand, M. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03596-8 · Cited by 2
Emerging new immune checkpoint inhibitors in solid tumor immunotherapy
Poorkhani, A., Tajaldini, M., Ahmadi, F., Tahmasebifar, A., Azadehrah, M., Azadehrah, M., Ghamoushiramandi, A., Amiri, R. S., & Khori, V. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04131-w · Cited by 3
Cancer Resistance to Immunotherapy
Khoury, R., Shayya, A., Orm, C. B., Deen, O. Z., & Ghanem, H. (2025) · Immuno · doi:10.3390/immuno5030032 · Cited by 2
Perspectives on the Role of T Cell Negative Immune Checkpoint Receptors in Health and Disease
Fujita, T., Clements, D. M., Premeaux, T. A., & Ndhlovu, L. C. (2020) · Springer eBooks · doi:10.1007/978-3-030-33946-3_6 · Cited by 2
Contribution of guanine nucleotide binding protein beta polypeptide 3 (GNB3) and lymphocyte activation gene 3 (LAG-3) to HIV susceptibility and immune dysfunction
Juno, J. A. (2010) · Mspace (University of Manitoba) · Cited by 2
NFATc1 regulates LAG3+CD8+ T cells in the spleen of mice infected with Plasmodium yoelii NSM
Pan, X., Mo, F., Li, P., Xiao, W. L., Liang, G., Xie, X., Yuan, H., Wei, H., Zhao, S., Li, L., et al. (2025) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0013605 · Cited by 1
Viruses Strive to Suppress Host Immune Responses and Prolong Persistence
Curtis, J., Seo, Y., & Hahm, B. (2012) · InTech eBooks · doi:10.5772/37894 · Cited by 1
The CD4-like molecule LAG-3, biology and therapeutic
Sierro, S. R., Romero, P. J., & Speiser, D. E. (2011) · Cited by 1
L’environnement acide de LAG3 dans les lymphocytes T perturbe l’association de la kinase Lck aux co-récepteurs CD4 et CD8 du TCR
Hivroz, C. (2022) · médecine/sciences · doi:10.1051/medsci/2022157 · Cited by 1
The involvement of Lymphocyte activation gene 3 and the inhibitor in non-small cell lung cancer
Lin, R. (2023) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v36i.5581 · Cited by 1
Introduction on Immune Checkpoints in Cancer
Balibegloo, M., & Rezaei, N. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_158-1 · Cited by 1
Lymphocyte activation gene-3 as a candidate target for combo anti-programmed death-(ligand) 1 therapy of cancer
Mortezaee, K. (2024) · Process Biochemistry · doi:10.1016/j.procbio.2023.12.018 · Cited by 1
LAG-3 Inhibitors for the Treatment of Lung Cancer
Sankpal, K., Morparia, S., Suvarna, V., & Murahari, M. (2024) · Springer eBooks · doi:10.1007/978-981-99-7141-1_8 · Cited by 1
Application of Immune Checkpoint Inhibitors in the Treatment of Renal Cell Carcinoma: Current Status, Challenges, and Future Directions
Ran, L., Zhao, R., Yu, L., Lin, B., Yang, Z., Teng, Y., Li, J., Wang, S., Liang, H. Y., & Hu, G. (2025) · AI Med · doi:10.71423/aimed.20250101 · Cited by 1
LAG-3 Role in Inflammatory Diseases
Chocarro, L., Blanco, E., Arasanz, H., Rubio, L. F., Echaide, M., Garnica, M., Ramos, P., Piñeiro, S., Kochan, G. T., & Escors, D. (2022) · MOL2NET International Conference on Multidisciplinary Sciences (MOL2NET) · doi:10.3390/mol2net-08-12447 · Cited by 1
Immune mediators of central nervous system demyelination and remyelination
Chen, V. S. (2008) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/v4b9-9109 · Cited by 1
Quality of CTL Therapies: A Changing Landscape
Thyagarajan, K., Chatterjee, S., Kesarwani, P., Nishimura, M. I., & Mehrotra, S. (2015) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-319-17807-3_14
Lymphocyte activation gene-3 : the expression and function in the immune system
Kisielow, M. (2006) · edoc (University of Basel) · doi:10.5451/unibas-003995280
OVERCOMING SELF-REACTIVITY THROUGH IMMUNOLOGICAL AND METABOLIC REDOX MODULATION
Delmastro-Greenwood, M. M. (2012) · D-Scholarship@Pitt (University of Pittsburgh)
Immunosenescence in Humans: Changes to the Aged T Lymphocyte Population in Response to Persistent Cytomegalovirus Infection
Aw, T.-R., & Chapman, J. (2015) · Journal of Immunology and Infectious Diseases · doi:10.15744/2394-6512.1.205
Novel Targets of Immune Inhibitory and Stimulatory Co-signals
Tamada, K. (2016) · Springer eBooks · doi:10.1007/978-4-431-55031-0_20
Lymphocyte Activation Gene-3 (CD223) Negative Regulation of T Cell Homeostasis by
Workman, C. J., & Vignali, D. A. A. (2017)
Self-citation
Exploring the Effect of Chronic Inflammation on Response to Immune Checkpoint Inhibitors in Cancer
El-Refai, S. M. (2018) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2018.045
Intrinsic Mechanisms Regulating T Cell Tolerance in Autoimmune Diabetes
Zhang, Q. (2018) · D-Scholarship@Pitt (University of Pittsburgh)
Therapeutic cancer vaccines
Berinstein, N. L., & Spaner, D. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3611-1.50045-3
Defining and targeting combination immunotherapies in mouse models of cancer
Demane, F., & Demane, D. F. (2019) · UCL Discovery (University College London)
Roles of γδ T Cells in Influenza Infections and Methods for TCR Expression and Characterization
Guo, X.-Z. J. (2019) · doi:10.21007/etd.cghs.2019.0483
Cancer Immunotherapy
Hasan, M. R., Alotaibi, B. S., Alnomasy, S. F., & Fakhri, K. U. (2020) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-6530-8.ch001
Estudio de las interacciones de PD-1H y sus ligandos en la respuesta inmunitaria murina = The study of the interactions between PD-1H and their putative ligands in the murine immune response
Soto, I. D. V. (2021) · doi:10.18002/10612/12813
Tumor Mutational Burden and Survival in Papillary Renal Cell Carcinoma PatientsPreprint
Ding, H., Shu, Y., Han, Y., Ji, Z., & Yang, P. (2021) · Research Square · doi:10.21203/rs.3.rs-303671/v1
Antibody‐Based Therapeutics in Oncology
Moore, P. A., Motte-Mohs, R. N. L., Li, J. C., & Chichili, G. R. (2017) · Methods and principles in medicinal chemistry · doi:10.1002/9783527699124.ch16
Identification and Validation of Immune-Related Gene Prognostic Signature for breast cancerPreprint
Zhou, B., Zhang, L., Wang, Q., Pu, C., Guo, S., Lai, S., Zhang, H., Li, W., Zhou, Z., Chen, Y., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-386385/v1
Research Progress of LAG-3 Molecule in Non-Small Cell Lung Cancer
王, 思. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.126865
Natural killer cell profiling in women with recurrent pregnancy loss
Habets, D. H. J. (2022) · doi:10.26481/dis.20220915dh
Beyond PD-1/PD-L1 Immune Checkpoint Inhibitors: Other Targets and Approaches for Head and Neck Cancer
Gavrielatou, N., Economopoulou, P., & Psyrri, A. K. (2022) · Cancer immunotherapy · doi:10.1007/13905_2022_30
Inmunoterapia en Melanoma: Rol de TIGIT y LAG-3 en el microambiente inmune antitumoral
Neira, G. C. G., Prieto, S. D. S., & Lagos, S. M. R. (2023) · CIENCIA EN DESARROLLO · doi:10.19053/01217488.v14.n2.2023.15041
The Biology of Immune Checkpoint Blockade
Bullock, T. N. J. (2024) · Wiley eBooks · doi:10.1002/9781119824572.ch10
Other Immune Checkpoint Targets of Interest
Csizmar, C. M., & Ansell, S. M. (2024) · Wiley eBooks · doi:10.1002/9781119824572.ch12
TCR Signals Controlling Adaptive Immunity against Toxoplasma and Cancer
Okamoto, M., & Yamamoto, M. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-9781-7_12 · Cited by 1
OX40 and CD40 Agonists for the Treatment of Lung Cancer
Verma, N., Thapa, K., Kanojia, N., Sood, P., Kumar, J., Thakur, N., & Dua, K. (2024) · Springer eBooks · doi:10.1007/978-981-99-7141-1_10
FGL-1 binding to LAG-3 inhibits T cell activation via disruption of CD28 and TCR signalingPreprint
Nyovanie, S., Hashem, A., Kanshin, E., Oltean, N., Ueberheide, B. M., Patskovsky, Y., & Krogsgaard, M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.05.668721
Development and characterization of Novel Small Molecule Inhibitors Targeting LAG-3 ProteinPreprint
Yakovenko, O., Baradaran‐Heravi, A., & Jones, S. J. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.29.673196
Immunotherapy for Cutaneous Melanoma
Soleymanitabar, A., Keshavarz‐Fathi, M., Hargadon, K. M., & Rezaei, N. (2025) · Springer eBooks · doi:10.1007/978-3-032-00769-8_237
Introduction on Immune Checkpoints in Cancer
Balibegloo, M., & Rezaei, N. (2025) · Springer eBooks · doi:10.1007/978-3-032-00765-0_158
Additional file 1 of A combined analysis of multi-omics data reveals the prognostic values and immunotherapy response of LAG3 in human cancers
Peng, J., Du, Z., Sun, Y., & Zhou, Z. (2023) · Figshare · doi:10.6084/m9.figshare.24873043
Additional file 4 of Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis
Li, R., Qiu, J., Zhang, Z., Qu, C., Tang, Z., Yu, W., Tian, Y., & Tian, H. (2024) · Figshare · doi:10.6084/m9.figshare.26648613
Additional file 7 of Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis
Li, R., Qiu, J., Zhang, Z., Qu, C., Tang, Z., Yu, W., Tian, Y., & Tian, H. (2024) · Figshare · doi:10.6084/m9.figshare.26648622
Additional file 2 of A combined analysis of multi-omics data reveals the prognostic values and immunotherapy response of LAG3 in human cancers
Peng, J., Du, Z., Sun, Y., & Zhou, Z. (2024) · Figshare · doi:10.6084/m9.figshare.24873145
Additional file 3 of Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis
Li, R., Qiu, J., Zhang, Z., Qu, C., Tang, Z., Yu, W., Tian, Y., & Tian, H. (2024) · Figshare · doi:10.6084/m9.figshare.26648610
Additional file 6 of Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis
Li, R., Qiu, J., Zhang, Z., Qu, C., Tang, Z., Yu, W., Tian, Y., & Tian, H. (2024) · Figshare · doi:10.6084/m9.figshare.26648619
Additional file 2 of Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis
Li, R., Qiu, J., Zhang, Z., Qu, C., Tang, Z., Yu, W., Tian, Y., & Tian, H. (2024) · Figshare · doi:10.6084/m9.figshare.26648607
Additional file 8 of Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis
Li, R., Qiu, J., Zhang, Z., Qu, C., Tang, Z., Yu, W., Tian, Y., & Tian, H. (2024) · Figshare · doi:10.6084/m9.figshare.26648625
Additional file 1 of Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis
Li, R., Qiu, J., Zhang, Z., Qu, C., Tang, Z., Yu, W., Tian, Y., & Tian, H. (2024) · Figshare · doi:10.6084/m9.figshare.26648604
Additional file 5 of Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis
Li, R., Qiu, J., Zhang, Z., Qu, C., Tang, Z., Yu, W., Tian, Y., & Tian, H. (2024) · Figshare · doi:10.6084/m9.figshare.26648616
T-cell exhaustion indicator characterizes the tumor microenvironment landscape and predicts colon adenocarcinoma prognosis via integrating single-cell RNA-seq and bulk RNA-sequencing
Sun, H., Hu, N., Ma, S., Zheng, Y., Niu, R., Zhu, W., & Qiu, S. (2026) · BMC Cancer · doi:10.1186/s12885-025-15535-5
Activation and lineage specific Lag3 expression dynamics in T cells
Khaled, C., kim, S., Kim, D., & Min, B. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkag039
Inhibitory receptor agonists: Emerging strategies in immune modulation
Adam, K. R., Suhail, A., Kuchroo, V. K., & Vignali, D. A. A. (2026) · The Journal of Experimental Medicine · doi:10.1084/jem.20241217
Self-citation
Impact direct du VEGF-A sur le microenvironnement immunitaire en situation tumorale : modulation par les anti-angiogéniques
Voron, T. (2019) · theses.fr (ABES) · doi:10.70675/56890e6bz5825z4192za96az7cb5ac8dae75
Role of Tissue-Resident Memory T (TRM) Cells in CD8+ T Cell Immunity and Response to Anti-PD-1 Immunotherapy : Involvement of TGF-β and αV Integrins
Malenica, I. (2019) · theses.fr (ABES) · doi:10.70675/410eb99fz6cbdz4f96z81bbze31bdbd1fabc
Rôle de la Neuropiline-1 dans les fonctions effectrices des lymphocytes T CD8 antitumoraux
Leclerc, M. (2018) · theses.fr (ABES) · doi:10.70675/13aee211zad7bz4b07z9a5fz29b15750d99c
Dichotomie cellules natural killer – cellules lymphoïdes innées de type 1 : développement et fonctions anti-tumorales
Vienne, M. (2020) · theses.fr (ABES) · doi:10.70675/d27fae11zc88bz4dc7za15dzd70186265ba2
Role of co-activating receptors CD226 and CD137 in T cell exhaustion
Pichler, A. (2020) · theses.fr (ABES) · doi:10.70675/ec9fb2bazf7a9z4305z9a58zb5cbc6e74e63
Contribution des réponses immunitaires adaptatives spécifiques des antigènes tumoraux à l'efficacité clinique de l'immunothérapie par inhibition de l'axe PD-1/PD-L1
Balança, C.-C. (2021) · theses.fr (ABES) · doi:10.70675/35353ecez3292z48f1z81ecz10edb0a3d321
Myeloid Malignancies Beyond the Cell: Targeting the Tumour Microenvironment with Next-Generation Immunotherapies
Amirian, N., Squires, A. M., Azanabor, L., Walker, C. A., Simmonds, M. J., & Rinaldi, C. R. (2026) · Cancers · doi:10.3390/cancers18111808
The metabolic roles of immune checkpoint molecules
Wang, Y., Wang, J., Dan, S., Zheng, J., Lu, Y., & Xia, F. (2026) · Endocrine Reviews · doi:10.1210/endrev/bnag030
Understanding the therapeutic significance of tumor-infiltrating immune cells and their characteristics: A historical overview of cancer immunotherapy
Nath, L., Borah, D., Kashyap, J., Saha, S., Sharma, D., Porasar, P., Pandey, J., Lamchhane, S., Upadhyay, A., & Dutta, K. N. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27731-3.00007-3
Lymphocyte activation gene 3 in autoimmune disease: from molecular mechanisms to clinical applications
Guo, L., Pan, L., Liu, C., & Yang, S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1904328
Inhibitory immune checkpoints in preeclampsia: current landscape, mechanisms, and clinical perspectives
Liu, M., Duan, G., Lai, X., Lin, B., Li, X., Yang, J., Cao, S., Chen, H., Wang, T., Chen, B., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1940260
The Lag3 KIEELE motif couples HPK1 to metabolic and functional regulation of Foxp3+ regulatory T cellsPreprint
Kim, G., Kim, D., Kim, S., & Min, B. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.28.755064
LAG3 checkpoint function and its mechanism of action in therapeutic targeting
Jiang, Y., Vignali, D. A. A., & Wang, H. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-026-01359-2
Self-citation

Authors: Workman, C. J., Dugger, K. J., & Vignali, D. A. A.
Affiliations: St. Jude Children's Research Hospital (US)
ORCID: Workman, Creg J
Dugger, Kari J
Vignali, Dario A A
Venue: The Journal of Immunology
Publisher: Oxford University Press (OUP)
Published: 2002-11
Volume: 169
Issue: 10
Pages: 5392-5395
ISSN: 0022-1767 (ISSN-L)
1550-6606
DOI: 10.4049/jimmunol.169.10.5392
OpenAlex: W1480698358
Cited by: 389
References: 26
Citations by year: 2026: 18 · 2025: 28 · 2024: 50 · 2023: 41 · 2022: 37 · 2021: 30 · 2020: 38 · 2019: 30 · 2018: 25 · 2017: 17 · 2016: 9 · 2015: 12 · 2014: 3 · 2013: 4 · 2012: 7
FWCI: 1.42
Type: journal article
Language: en
Open access: closed
Licence: academic.oup.com/pages/standard-publication-reuse-rights (vor)
Locations: The Journal of Immunology (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (CA-09346, T32CA009346, CA23944, CA21765, R25CA023944, P30CA021765)
National Institute of Allergy and Infectious Diseases (T32AI007372, AI-07372, AI39480)
Topics: Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
Keywords: LAG-3, T cell regulation, MHC class II binding, cytoplasmic domain, negative regulation of T cell activation
MeSH terms: Lymphocyte Activation Gene 3 Protein, Amino Acid Sequence, Animals, Histocompatibility Antigens Class II, Cytoplasm, Humans, Hybridomas, Ligands, Lymphocyte Activation, Membrane Proteins, Molecular Sequence Data, Tumor Cells, Cultured, Down-Regulation, Antigens, CD, CD4 Antigens, Conserved Sequence, Protein Structure, Tertiary, Amino Acid Motifs, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cutting Edge: Molecular Analysis of the Negative Regulatory Function of Lymphocyte Activation Gene-3

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks